An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About Mitchell Cancer Institute Kilborn Clinic
As an academic medical cancer center, USA Health provides the most comprehensive, advanced treatment for patients with cancer.
Here are some of the treatments and amenities we currently offer at the Mitchell Cancer Institute Kilborn Clinic:
- Medical and radiation oncology
- 16 recliners for patients receiving chemotherapy infusion
- State-of-the-art radiation therapy
- Clinical trials
- Genetic testing
- Support groups
- Education sessions
Mitchell Cancer Institute Kilborn Clinic hours of operation is Monday–Friday, 8 a.m. to 5 p.m.